STAT

NOVEMBER 26, 2023

LONDON — The inflammation-targeting therapy Dupixent succeeded in a Phase 3 trial in patients with the chronic lung disease COPD, its developers said Monday, results that could propel the blockbuster medicine into a massive new market. Dupixent, which is jointly developed by Sanofi and Regeneron Pharmaceuticals, has already racked up approvals for several indications, including asthma, atopic dermatitis, and eosinophilic esophagitis.

Drug Development 276

Drug Development 276

The Guardian - Pharmaceutical Industry

NOVEMBER 26, 2023

Patients’ group says reactions to metamizole can cause sepsis and organ failure – and British and Irish people are at higher risk A patients group representing several British victims has launched legal action against the Spanish government over claims it failed to safeguard people against the potentially fatal side effects of one of the country’s most popular painkillers, involved in a series of serious illnesses and deaths.

119

119

ID Stewardship

NOVEMBER 26, 2023

In this article 3 clinical pharmacists provide insights, pulling from their advanced experience with beta-lactam therapeutic drug monitoring (TDM). Photo pending Authored By : Kathryn DeSear, PharmD; Barbara Santevecchi, PharmD; Veena Venugopalan, PharmD; Lisa Vuong PharmD Article Posted 28 November 2023 Beta-lactam antibiotics are time-dependent antibiotics, which means that by increasing the time the free drug concentration remains above the minimum inhibitory concentration (% f T>MIC) of

Nursing Homes 94

Nursing Homes Hospitals Dosage 94

Express Pharma

NOVEMBER 26, 2023

This study was conducted in Europe and India to examine the effects of giving patients injectable 12 mg versus 6 mg of dexamethasone every day for a maximum of 10 days There may be important regional differences in the response to higher doses of steroids (dexamethasone) for patients with severe COVID-19, according to a recent sub-study of the COVID-STEROID 2 trial.

Adverse Reactions 91

Adverse Reactions Diabetes Hospitals 91

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Joe

NOVEMBER 26, 2023

In this episode, I’ll discuss 5 steps an ED or ICU pharmacist can take to prevent awareness with paralysis. Episode 873: 5 Steps an ED or ICU pharmacist can take to prevent awareness with paralysis Subscribe on iTunes , Android , or Stitcher Awareness with paralysis occurs when a patient receives a paralytic for rapid sequence intubation but does not receive ongoing sedation before the induction agent wears off.

Hospitals 52

Hospitals Inpatient Labelling 52

Med Ed 101

NOVEMBER 26, 2023

In this case, I outline a unique situation involving stimulants and elderly patients. I outline some of the potential complications and contributions to the prescribing cascade. A 76-year-old female resides in an assisted living. She has a history of ADHD, anxiety, insomnia, diabetes, hypertension, back pain, and GERD. Her current medication list includes the following: […] The post Stimulants and Elderly Patients – Case Study appeared first on Med Ed 101.

Assisted Living 52

Assisted Living Diabetes 52